Friday, June 23, 2017 5:44:49 PM
DISCOVERY HARBOUR ANNOUNCES PROPOSED AMENDMENT TO UNSECURED CONVERTIBLE DEBENTURE AND CONSOLIDATION
Discovery Harbour Resources Corp. has agreed to amend the unsecured convertible debenture in the principal amount of $100,000 issued to Richard Gilliam, a director and significant shareholder of the company, as previously announced in its news releases of March 24, 2017, and April 7, 2017. The Company and Richard Gilliam have agreed to amend the conversion terms of the Debenture from convertible into common shares of the Company to convertible into units (each, a "Unit") of the Company at the greater of $0.05 per Unit or the subscription price for each share in the most recently completed private placement of the Company during the term of the Debenture, subject to adjustment. Each Unit will consist of one common share (each, a "Share") and one non-transferable share purchase warrant (each, a "Warrant"). Each Warrant will be exercisable into one Share at an exercise price equal to the greater of $0.075 per Share or the warrant exercise price, if any, for each warrant issued in the most recently completed private placement of the Company during the term of the Debenture, subject to adjustment, for a period of one year from April 7, 2017, with an acceleration clause that if the closing share trading price meets or exceeds $0.20 for 10 consecutive trading days then notice can be given that the Warrants must be exercised within 30 days from notice. All other terms of the Debenture shall remain the same. The Amendment is subject to the approval of the TSX Venture Exchange (the "Exchange").
Richard Gilliam is considered a "related party" within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101") and the Amendment is therefore considered to be a "related party transaction" within the meaning of MI 61-101. The Amendment, however, is exempt from the valuation requirement and from the minority shareholder approval requirements of MI 61-101 by virtue of the exemptions contained in sections 5.5(a) and 5.7(1) (a) of MI 61-101 in that the fair market value of the consideration of the Debenture issued to the related party did not exceed 25% of the Company's market capitalization. This News Release is being filed less than 21 days before the Amendment being approved because the Company wishes to complete the Amendment in a timely manner.
The Company also announces that it intends to proceed with a consolidation of its outstanding common Shares on the basis of three (3) pre-consolidation Shares for one (1) post-consolidation Share (the "Consolidation").
Currently, a total of 53,393,513 Shares are issued and outstanding. Accordingly, if the Consolidation is completed, a total of 17,797,838 Shares would be issued and outstanding, subject to adjustments for rounding and assuming there are no other changes in the issued capital of the Company. There is currently no maximum number of authorized Shares. There is no name change in conjunction with the Consolidation. The Consolidation is subject to the approval of the Exchange
Recent DHR News
- Danaher Schedules Third Quarter 2024 Earnings Conference Call • PR Newswire (US) • 09/19/2024 08:30:00 PM
- Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership • PR Newswire (US) • 09/17/2024 12:30:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 09/10/2024 08:15:00 PM
- Danaher Confirms Third Quarter and Full Year 2024 Guidance • PR Newswire (US) • 09/04/2024 08:30:00 PM
- Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C. • PR Newswire (US) • 08/26/2024 09:30:00 PM
- Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration • PR Newswire (US) • 07/25/2024 01:00:00 PM
- Danaher Reports Second Quarter 2024 Results • PR Newswire (US) • 07/23/2024 10:00:00 AM
- Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development • PR Newswire (US) • 07/17/2024 11:30:00 AM
- Danaher Releases 2024 Sustainability Report • PR Newswire (US) • 07/16/2024 11:30:00 AM
- Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening • PR Newswire (US) • 07/11/2024 11:30:00 AM
- Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer • PR Newswire (US) • 07/09/2024 07:00:00 AM
- Danaher Schedules Second Quarter 2024 Earnings Conference Call • PR Newswire (US) • 06/24/2024 08:30:00 PM
- Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics • PR Newswire (US) • 06/19/2024 11:30:00 AM
- Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer • PR Newswire (US) • 06/05/2024 11:00:00 AM
- Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis • PR Newswire (US) • 05/09/2024 11:00:00 AM
- Danaher to Present at Bank of America Securities Healthcare Conference • PR Newswire (US) • 05/07/2024 08:45:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 05/07/2024 08:15:00 PM
- Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry • PR Newswire (US) • 05/03/2024 01:06:00 PM
- Danaher Reports First Quarter 2024 Results • PR Newswire (US) • 04/23/2024 10:00:00 AM
- Danaher Schedules First Quarter 2024 Earnings Conference Call • PR Newswire (US) • 03/21/2024 08:15:00 PM
- Danaher to Present at TD Cowen Health Care Conference • PR Newswire (US) • 02/27/2024 09:15:00 PM
- Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets • PR Newswire (US) • 02/22/2024 09:15:00 PM
- Danaher Announces Quarterly Dividend • PR Newswire (US) • 02/21/2024 09:15:00 PM
- Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development • PR Newswire (US) • 02/05/2024 12:30:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM